As filed with the Securities and Exchange Commission on July 27, 2023

Registration No. 333-

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-8

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

 

CELESTICA INC.

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

 

ONTARIO, CANADA		98-0185558
(STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION)		(I.R.S. EMPLOYER IDENTIFICATION NO.)

 

5140 Yonge Street, Suite 1900
Toronto, Ontario, Canada		M2N 6L7
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)		(ZIP CODE)

 

LONG-TERM INCENTIVE PLAN

(FULL TITLE OF THE PLAN)

 

Arnold & Porter Kaye Scholer LLP
Attention: Managing Attorney
250 West 55th Street, New York, New York 10019-9710

(NAME AND ADDRESS OF AGENT FOR SERVICE)

 

(212) 836-8000

(Telephone number, including area code, of agent for service)

 

copies to:

 

Joel I. Greenberg, Esq. Sara Adler, Esq. Arnold & Porter Kaye Scholer LLP 250 West 55th Street New York, N.Y. 10019-9710 (212) 836-8000

Matthew Merkley, Esq. Blake, Cassels & Graydon LLP 199 Bay Street, Suite 4000 Commerce Court West Toronto, Ontario M5L 1A9 Canada (416) 863-2400

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	¨	Smaller reporting company	¨
		Emerging growth company	¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

 

 

 

EXPLANATORY NOTE

 

This Registration Statement is being filed by Celestica Inc. (the “Company”), in accordance with General Instruction E of Form S-8, to register 393,472 additional subordinate voting shares issuable to specified persons under the Company’s amended and restated Long-Term Incentive Plan (the “LTIP”). The contents of the Company’s Registration Statement on Form S-8 (No. 333-9500) filed with the Securities and Exchange Commission (the “Commission”) on October 8, 1998, its Registration Statement on Form S-8 (No. 333-63112) filed with the Commission on June 15, 2001, its Registration Statement on Form S-8 (No. 333-88210) filed with the Commission on May 14, 2002, and its Registration Statement on Form S-8 (No. 333-266330) filed with the Commission on July 26, 2022 (and amended by Post-Effective Amendment No. 1 filed on March 9, 2023) are incorporated by reference into this Registration Statement, except to the extent supplemented, amended or superseded by the information set forth herein, or by any subsequently filed document that is incorporated by reference herein or therein.

 

PART II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 3.

Incorporation of Documents by Reference

 

The Company hereby incorporates by reference into this Registration Statement the following documents:

 

(a)

the Company’s Annual Report on Form 20-F for the year ended December 31, 2022 filed with the Commission on March 13, 2023;

 

(b)

Exhibit 99.1 to the Company’s Report on Form 6-K furnished to the Commission on January 26, 2023, containing its Unaudited Interim Condensed Consolidated Financial Statements for the quarter and year ended December 31, 2022, and the accompanying notes thereto;

 

(c)

Exhibit 99.1 and Exhibit 99.2 to the Company’s Report on Form 6-K furnished to the Commission on April 26, 2023, containing, respectively, its Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three months ended March 31, 2023, and its Unaudited Interim Condensed Consolidated Financial Statements for the three months ended March 31, 2023 and the accompanying notes thereto;

 

(d)

Exhibit 99.1 and Exhibit 99.2 to the Company’s Report on Form 6-K furnished to the Commission on July 26, 2023, containing, respectively, its Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three and six months ended June 30, 2023, and its Unaudited Interim Condensed Consolidated Financial Statements for the three and six months ended June 30, 2023 and the accompanying notes thereto; and

 

(e)

The description of the Company’s subordinate voting shares contained in its Registration Statement on Form 8-A, effective as of June 29, 1998, as amended by the description in Exhibit 2.3 to its Annual Report on Form 20-F for the year ended December 31, 2022.

 

Each of the following documents filed with or furnished to the Commission after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, are deemed to be incorporated by reference in the Registration Statement and to be a part thereof from the date of filing or furnishing such documents: (i) all Annual Reports on Form 20-F the Company files with the Commission; and (ii) those portions of any Reports on Form 6-K the Company furnishes to the Commission that the Company indicates in such reports are to be deemed incorporated by reference into this Registration Statement.

 

Any statement contained herein, or in any document (or portion thereof) incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed or furnished document (or portion thereof) which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed to constitute a part of this Registration Statement, except as so modified or superseded.

 

 

Item 8.

Exhibits.

 

EXHIBIT NUMBER		DESCRIPTION
4.1		Form of Subordinate Voting Share Certificate (1)
4.2		Certificate and Restated Articles of Incorporation effective June 25, 2004 (2)
4.3		Bylaw No. 1 (2)
4.4		Amended and Restated Celestica Long-Term Incentive Plan (3)
5.1		Opinion of Blake, Cassels & Graydon LLP*
5.2		Consent of Blake, Cassels & Graydon LLP (included in opinion filed as Exhibit 5.1)*
23.1		Consent of KPMG LLP, independent registered public accounting firm*
24.1		Power of Attorney (included in the signature page to this Registration Statement)*
107		Filing Fee Table*

 

* Filed herewith.

 

(1)	Incorporated by reference to Registration Statement on Form F-3ASR (File No. 333-221144) filed on October 26, 2017.
(2)	Incorporated by reference to Annual Report on Form 20-F filed on March 23, 2010 (File No. 001-14832).

(3)	Incorporated by reference to Annual Report on Form 20-F filed on March 13, 2017 (File No. 001-14832).

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Toronto, Province of Ontario, Country of Canada, on the 26^th day of July, 2023.

 

	CELESTICA INC.
	By:	/s/ Robert A. Mionis
	Robert A. Mionis
	President and Chief Executive Officer

 

POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Robert A. Mionis, Mandeep Chawla and Robert Ellis, and each of them, as such individual’s true and lawful attorney in fact and agent with full power of substitution, for such individual in any and all capacities, to sign any and all amendments to this Registration Statement on Form S-8 (including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Commission, granting unto said attorney in fact, proxy and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney in fact, proxy and agent, or the individual’s substitute, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.

 

SIGNATURE	TITLE	DATE
/s/ Robert A. Mionis	Director, President and Chief	July 26, 2023
Robert A. Mionis	Executive Officer
	(Principal Executive Officer)
/s/ Mandeep Chawla	Chief Financial Officer	July 26, 2023
Mandeep Chawla	(Principal Financial Officer and
	principal accounting officer)
/s/ Michael Wilson	Chair of Board and Director	July 26, 2023
Michael Wilson
/s/ Robert A. Cascella	Director	July 26, 2023
Robert A. Cascella
/s/ Deepak Chopra	Director	July 26, 2023
Deepak Chopra

 

 

/s/ Françoise Colpron	Director	July 26, 2023
Françoise Colpron
/s/ Daniel P. DiMaggio	Director	July 26, 2023
Daniel P. DiMaggio
/s/ Jill Kale	Director	July 26, 2023
Jill Kale
/s/ Laurette T. Koellner	Director	July 26, 2023
Laurette T. Koellner
/s/ Luis A. Müller	Director	July 26, 2023
Luis A. Müller
/s/ Tawfiq Popatia	Director	July 26, 2023
Tawfiq Popatia

 

AUTHORIZED REPRESENTATIVE

 

Pursuant to the requirements of Section 6(a) of the Securities Act, the undersigned has signed this Registration Statement, solely in the capacity of the duly authorized representative of Celestica Inc. in the United States, on the 26th day of July, 2023.

 

	CELESTICA INC.
	(Authorized U.S. Representative)
	By:	/s/ Robert Ellis
		Name: Robert Ellis
		Title:  Chief Legal Officer and Corporate Secretary

 

 

EXHIBIT INDEX

 

Exhibit Number	Description of Exhibit
5.1	Opinion of Blake, Cassels & Graydon LLP
5.2	Consent of Blake, Cassels & Graydon LLP (included in opinion filed as Exhibit 5.1)
23.1	Consent of KPMG LLP, independent registered public accounting firm
107	Filing Fee Table

 

 

 

Exhibit 5.1

 

 

 

July 27, 2023

 

Celestica Inc.

5140 Yonge Street, Suite 1900

Toronto, Ontario

Canada M2N 6L7

 

Re:	Celestica Inc. Registration Statement on Form S-8

 

Dear Sirs/Mesdames:

 

We have acted as Canadian counsel to Celestica Inc. (the “Company”) in connection with the Registration Statement on Form S-8 (the “Registration Statement”) filed on July 27, 2023 by the Company with the U.S. Securities and Exchange Commission (the “Commission”) under the U.S. Securities Act of 1933, as amended (the “Act”), relating to the registration by the Company for its issue and sale from time to time of subordinate voting shares (the “SVS”) in its capital.

 

This opinion letter is being provided at the request of the Company. As Canadian counsel for the Company, we have examined a copy of the Registration Statement.

 

We are solicitors qualified to practice law in the Province of Ontario and the opinions expressed herein relate only to the laws of the Province of Ontario and the laws of Canada applicable therein as in effect on the date hereof.

 

In connection with the opinions expressed in this opinion letter, we have considered such questions of law, examined originals or copies of such statutes, regulations, documents, records, certificates and instruments and conducted such other examinations as we have considered necessary. In such examinations, we have assumed the legal capacity of all individuals, the genuineness of all signatures, the authenticity of all documents submitted to us as originals and the conformity to authentic original documents of all documents submitted to us as certified, conformed, photostatic or facsimile copies.

 

We have also assumed that at all relevant times:

 

1.	the Company is validly existing under the Business Corporations Act (Ontario) and has the necessary corporate power and capacity to own its property and assets and to carry on its business;

 

2.

the Company has the necessary corporate power and capacity to execute, deliver and perform its obligations under the terms and conditions of any grant, purchase, underwriting or other agreement, plan or instrument relating to the Company’s creation, authentication, issuance, sale and/or delivery of the SVS to which the Company is party (any such agreement, the “Agreement”);

 

 

 

 

 

Page 2

 

3.	the Company has the necessary corporate power and capacity to authorize, create, authenticate, validly issue, sell and deliver the SVS and perform its obligations under the terms and conditions of the SVS;

 

4.	all necessary corporate action has been taken by the Company to duly authorize the execution and delivery by the Company of the Agreement and the performance of its obligations under the terms and conditions thereof;

 

5.	all necessary corporate action has been taken by the Company to duly authorize, create, authenticate, sell, deliver and validly issue the SVS and to perform its obligations under the terms and conditions of the SVS;

 

6.	all necessary corporate action has been taken by the Company to duly authorize the terms of the offering of the SVS and related matters;

 

7.	the Agreement: (i) has been duly authorized, executed and delivered by all parties thereto and such parties had the capacity to do so; (ii) constitutes a legal, valid and binding obligation of all parties thereto; and (iii) is enforceable in accordance with its terms against all parties thereto;

 

8.	the SVS have been duly authorized, created, authenticated, sold and delivered and validly issued by the Company and any other person signing or authenticating the SVS, as applicable;

 

9.	the terms of the offering of the SVS and related matters have been duly authorized by the Company;

 

10.	the Company shall have received, in respect of any issue of SVS not issued for money, property or past service that is not less in value than the fair equivalent of the money that the Company would have received if the SVS had been issued for money;

 

11.

the execution and delivery of the Agreement and the performance by the Company of its obligations under the terms and conditions thereunder do not and will not conflict with and do not and will not result in a breach of or default under, and do not and will not create a state of facts which, after notice or lapse of time or both, will conflict with or result in a breach of or default under any of the terms or conditions of the articles or by-laws of the Company, any resolutions of the Board of Directors or shareholders of the Company, any agreement or obligation of the Company, or applicable law;

 

12.

the authorization, creation, authentication, sale, delivery and issuance of the SVS and the Company’s performance of its obligations under the terms and conditions of the SVS do not and will not conflict with and do not and will not result in a breach of or default under, and do not and will not create a state of facts which, after notice or lapse of time or both, will conflict with or result in a breach of or default under any of the terms or conditions of the articles or by-laws of the Company, any resolutions of the Board of Directors or shareholders of the Company, any agreement or obligation of the Company, or applicable law; and

 

 

 

 

 

Page 3

 

13.

the terms of the offering of the SVS and related matters do not and will not conflict with and do not and will not result in a breach of or default under, and do not and will not create a state of facts which, after notice or lapse of time or both, will conflict with or result in a breach of or default under any of the terms or conditions of the articles or by-laws of the Company, any resolutions of the Board of Directors or shareholders of the Company, any agreement or obligation of the Company, or applicable law.

 

Based upon the foregoing, and subject to the qualifications, assumptions and limitations stated herein, we are of the opinion that, upon payment for the applicable SVS provided for in the applicable Agreement and otherwise in accordance with such Agreement, the SVS will be validly issued, fully paid and non-assessable shares in the capital of the Company.

 

We hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Registration Statement and to the use of our name under the caption “Legal Matters” in the Prospectus included in the Registration Statement. In giving this opinion, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.

 

	Yours very truly,
	/s/ Blake, Cassels & Graydon LLP

 

 

 

 

 

Exhibit 23.1

 

 

 

KPMG LLP

Bay Adelaide Centre

333 Bay Street, Suite 4600

Toronto, Ontario, M5H 2S5

Telephone (416) 777-8500

Fax (416) 777-8818

www.kpmg.ca

 

Consent of Independent Registered Public Accounting Firm

 

The Board of Directors

Celestica Inc.

 

We consent to the use of our report dated March 9, 2023, on the consolidated financial statements of Celestica Inc. (the “Entity”), which comprise the consolidated balance sheets as of December 31, 2022 and December 31, 2021, the related consolidated statements of operations, comprehensive income, changes in equity and cash flows for each of the years in the three-year period ended December 31, 2022, and the related notes and our report dated March 9, 2023 on the effectiveness of internal control over financial reporting as of December 31, 2022 which are incorporated by reference in this Registration Statement on Form S-8 of the Entity and are included in the Entity’s Annual Report on Form 20-F filed with the United States Securities and Exchange Commission on March 13, 2023.

 

/s/ KPMG LLP

Chartered Professional Accountants, Licensed Public Accountants

July 27, 2023

Toronto, Canada

 

KPMG LLP, an Ontario limited liability partnership and member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee.

KPMG Canada provides services to KPMG LLP.

 

 

 

Exhibit 107

 

Calculation of Filing Fee Table

Form S-8

(Form Type)

 

Celestica Inc.

(Exact name of registrant as specified in its charter]

 

Table 1: Newly Registered Securities

 

Security Type	Security Class Title	Fee Calculation Rule	Amount Registered(1)	Proposed Maximum Offering Price Per Unit	Maximum Aggregate Offering Price	Fee Rate	Amount of Registration Fee
Equity	Subordinate Voting Shares  without par value (SVS)	Other	298,954 SVS	$13.3009 (2)	$3,976,357.26 (2)	$0.00011020	$438.19
	SVS	Other	94,518 SVS	$10.58 (3)	$1,000,000.44 (3)	$0.00011020	$110.20
Total Offering Amounts					$4,976,357.70		$548.39
Total Fee Offsets							--
Net Fee Due							$548.39

 

(1)

This registration statement covers 393,472 SVS issuable with respect to stock options previously granted under Celestica’s amended and restated Long-Term Incentive Plan. Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (Securities Act), this Registration Statement shall also cover any additional SVS which become issuable under the pursuant to anti-dilution and adjustment provisions thereof resulting from stock splits, stock dividends or similar transactions.

 

(2)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) promulgated under the Securities Act. The “Proposed Maximum Offering Price Per Unit” and “Maximum Aggregate Offering Price” are based on the option exercise price (Cdn$17.52), converted into U.S. dollars ($13.3009) based on the average daily exchange rate for United States dollars as reported by the Bank of Canada on July 24, 2023, of Cdn $1.00 = US$0.759186.

 

(3)	Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) promulgated under the Securities Act. The “Proposed Maximum Offering Price Per Unit” and “Maximum Aggregate Offering Price” are based on the option exercise price.